Carvedilol Tablet, Film Coated
Product Images NDC 68382-092

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68382-092). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 01

Chemical structure of carvedilol, showing its molecular configuration including rings and side chains associated with the active ingredient carvedilol.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 02

A line graph showing % mortality over 21 months comparing Carvedilol versus placebo. The vertical axis represents % mortality from 0 to 30%, and the horizontal axis represents months from 0 to 21. Two curves indicate mortality rates, with Carvedilol showing lower mortality compared to placebo. A p-value of 0.0014 is noted on the graph.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 03

A forest plot chart displaying hazard ratios with confidence intervals for various patient subgroups including gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure levels, and spironolactone use. The chart shows relative risks for these categories compared to a reference line at 1.0.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 04

A line graph comparing the percentage mortality over 24 months between Carvedilol and placebo groups. The x-axis represents months from 0 to 24, and the y-axis shows percentage mortality from 0% to 30%. The graph shows that mortality increases over time for both groups, with the placebo group exhibiting higher mortality than the Carvedilol group, indicating a treatment effect. A p-value of 0.03 is noted on the graph.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 05

A forest plot chart displaying hazard ratios for various patient subgroups, including age, gender, prior myocardial infarction timing, prior use of Ivoral beta-blockers, Killip class, thrombolytic therapy status, PTCA use, congestive heart failure status, diuretic use, angina presence, hypertension, diabetes, heart rate, and systolic blood pressure. The data points represent relative risk with confidence intervals for each subgroup.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 06

Carvedilol Tablets, USP 3.125 mg film-coated tablets in a package label by Zydus Pharmaceuticals USA Inc. This label shows round white tablets marked with '1' and '2', package contains 100 tablets, Rx only, with storage and safety instructions. Manufactured by Cadila Healthcare Ltd., India, distributed by Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 07

Carvedilol 6.25 mg film-coated tablets label from Zydus Pharmaceuticals USA Inc. The label shows the drug name, strength, and tablet count of 100. The label includes dosage form, storage instructions, and safety warnings. It is marked Rx only and indicates distribution by Zydus Pharmaceuticals in Pennington, NJ.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 08

Carvedilol Tablets, USP 12.5 mg film-coated oral tablets, packaging label showing a round tablet imprinted with "ZC41." This label is for a bottle containing 100 tablets, distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions and safety warnings, and notes prescription-only use.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 09

Carvedilol Tablets USP 25 mg film-coated oral tablets, packaged in a bottle containing 100 tablets. The label shows the Zydus Pharmaceuticals logo and indicates the product is for prescription use only. Storage instructions and warnings about child safety and container handling are also visible. The manufacturer is Cadila Healthcare Ltd., India, and the distributor is Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.